当前位置： SCI文献检索 > JOURNAL OF DIABETES AND ITS COMPLICATIONS期刊下所有文献 > The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.

The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.

Abstract：

INTRODUCTION:Diabetic polyneuropathy aetiology is based on oxidative stress generation due to production of reactive oxygen species. Ubiquinone is reduced to ubiquinol and redistributed into lipoproteins, possibly to protect them from oxidation. AIMS:To evaluate the impact of oral ubiquinone in diabetic polyneuropathy, and the role of lipid peroxidation (LPO) and nerve growth factor (NGF-β). METHODS:We conducted a double-blind, placebo-controlled clinical trial, patients were randomized to ubiquinone (400 mg) or placebo daily for 12 weeks. Main outcomes were clinical scores, nerve conduction studies, LPO, NGF-β and safety. RESULTS:Twenty four patients on experimental group and twenty five on control group met the inclusion criteria (mean age 56 years, 22% male and 78% female, mean evolution of type 2 diabetes mellitus 10.7 years). Significant improvement on experimental vs control group was found in neuropathy symptoms score (from 2.5 ± 0.7 to 1 ± 0.8, p<0.001), neuropathy impairment score (5.5 ± 4 to 3.1 ± 2.6, p<0.001), sural sensory nerve amplitude (13.0 ± 6.1 to 15.8 ± 5.1 μV, p=0.049), peroneal motor nerve conduction velocity (39.7 ± 5.0 to 47.8 ± 4.9 m/s, p=0.047), and ulnar motor nerve conduction velocity (48.8 ± 6.8 to 54.5 ± 6.1m/s, p=0.046). There was a significant reduction of LPO in subjects treated with ubiquinone vs placebo (16.7 ± 8.6 and 23.2 ± 15.8 nmol/mL, respectively) with p<0.05, and NGF-β did not change (control 66.5 ± 26.7 vs. experimental 66.8 ± 28.4 pg/mL, p=0.856). No drug-related adverse reactions were reported. CONCLUSIONS:Twelve weeks treatment with ubiquinone improves clinical outcomes and nerve conduction parameters of diabetic polyneuropathy; furthermore, it reduces oxidative stress without significant adverse events.

journal_name

J Diabetes Complications

journal_title

Journal of diabetes and its complications

authors

Hernández-Ojeda J,Cardona-Muñoz EG,Román-Pintos LM,Troyo-Sanromán R,Ortiz-Lazareno PC,Cárdenas-Meza MA,Pascoe-González S,Miranda-Díaz AG

doi

10.1016/j.jdiacomp.2012.04.004

subject

Has Abstract

pub_date

2012-07-01 00:00:00

pages

352-8

issue

eissn

1056-8727

issn

1873-460X

pii

S1056-8727(12)00072-4

journal_volume

pub_type

杂志文章,随机对照试验

在线工具

The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.